Two B.C. youth receive first-in-Canada treatment to delay Type 1 diabetes Vancouver Sun 14:10 Thu, 30 Apr
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes PR Newswire (Press Release) 01:12 Mon, 27 Apr
Large human islet study reveals new insights into diabetes risk News-Medical.Net 12h Insulin Global Health Health
Diabetes 'wonder drug' doesn't work like expected – but it's good news Refractor 5d Health Global Health Science
Teens with T1D, obesity reaped benefits of GLP-1s, case studies suggest Medpage Today 5d Ozempic Insulin Obesity
Compared to estimates, Tandem Diabetes Care (tndm) Q1 earnings: A look at key metrics Zacks 6d Health
How football is proving a men's mental health lifeline Wigan Today 2h Mental Health Wellbeing Men's Mental Health Article paywall
Hope for deadly brain cancer as first-of-its-kind personalized vaccine found to double survival time MailOnline 1d Cancer Cancer Treatment Nature Article paywall
Cellular Intelligence scoops up Novo's Parkinson's therapy pharmaphorum 1d Novo Nordisk Parkinson's Disease Pharma
